Last reviewed · How we verify

NCT03076944

Evaluation of Desensitization Protocols in Reduction of Dentin Hypersensitivity: A Randomized Clinical Trial

Status unknown NA Last updated 27 March 2017
What this trial tests

NA trial testing UltraEZ in Hypersensitivity Dentin in 32 participants. Status unknown.

Timeline
20 March 2017
Primary endpoint
1 November 2017
1 March 2018

Quick facts

Lead sponsorFederal University of Uberlandia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment32
Start date20 March 2017
Primary completion1 November 2017
Estimated completion1 March 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Uberlandia

Who can join

Adults 18 to 50, any sex, with Hypersensitivity Dentin or Dentin Sensitivity. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The aim of this study is through a double blind randomized clinical trial, evaluate the effectiveness of different clinical protocols in the reduction of dentin hypersensitivity. The desensitization approach (single agent or associated agents) and the long-term effectiveness (baseline, 1 week, 2 weeks, 4 weeks, 12 weeks and 24 weeks) will be evaluated. Data will be collected, tabulated and submitted to statistical analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of UltraEZ

Trials testing the same drug.

Other recruiting trials for Hypersensitivity Dentin

Currently open trials in the same condition.

Other Federal University of Uberlandia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03076944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing